Jessa Hospital, evaluating BugSeq for characterization of antimicrobial resistance and outbreak analysis in Pseudomonas aeruginosa, found “the overall categorical agreement (% [95% CI]) between AMR genotype and phenotype was 94.76% [92.46%–96.52%]”. Read more: doi.org/10.1128/jcm....

Applicability of Nanopore-only whole-genome sequencing for Pseudomonas aeruginosa outbreak investigation in the ICU setting: a multicentric study | Journal of Clinical Microbiology

In recent years, Nanopore sequencing has found its way to clinical laboratories because of its affordability, scalability, and, most importantly, its ability to obtain sequencing results in near-real ...

doi.org

Speed up your lab's #Cyclospora surveillance with the BugSeq platform. Contact us for early access to our new Cyclospora cayetanensis MLST module, which delivers typing from WGS and metagenomics!

We’re proud to team up with @genomebc.bsky.social on a new initiative to advance #Genomics in the fight against antimicrobial resistance! From scaling our #BugAMR platform to refining tools for rapid pathogen detection, we’re focused on one goal: faster, life-saving insights for healthcare.

Genome BC@genomebc.bsky.social · 4w ago

2 new research projects with BC-based biotech company @bugseq.com to advance genomic tools that improve antimicrobial resistance prediction and respiratory pathogen detection. Faster answers. Better treatment decisions. Stronger public health systems. www.genomebc.ca?p=36516

Fantastic demonstration by the @adventhealth.bsky.social team of the power of BugSeq in clinical practice: “Rapid and Routinely 24-Hour Antimicrobial Resistance Report for Mycobacterium abscessus Group by Whole-Genome Sequencing: A Tool for Appropriate Antimicrobial Therapy” 👇

#asmicrobe | Daniel Navas

A huge thank you to everyone who stopped by my poster at #ASMicrobe 2026! It was great meeting so many people and discussing the future of Microbiology. Here is a closer look at this year's poster pre...

linkedin.com

Check out recent updates to the BugSeq platform in our latest blog post: Advancing Viral Surveillance, Sequencing Flexibility, AMR Prediction, and EPI2ME Integration docs.bugseq.com/blog/2026/05...

Discover how public health laboratories are integrating BugSeq into their everyday bioinformatics routines! Visit us at booth 200 at @aphl.org 2026; we are eager to learn about the challenges you face and discuss how our solutions can support your work. #APHL

At #PASCV2026 ? Drop by the BugSeq booth (02T) to see how the most innovative labs are leveraging NGS to track viral outbreaks, antiviral resistance and more (and don’t forget to grab a notebook or bag)!

⏰ 16:15-17:15 CEST 📍 #Bioinformatics Pipeline Corner, Arena 4 🗣️ Sam Chorlton, BugSeq CEO See how we leverage interpretable AI to aid clinical translation and deliver industry-leading accuracy in: 🦠 Pathogen ID 💊 AMR prediction 📈 Outbreak analysis #ESCMIDGlobal2026

At #ESCMIDGlobal2026? Come visit booth H11 to learn more about how BugSeq can power your infectious disease bioinformatic workflows! From pathogen identification to AMR and outbreak analysis, BugSeq has a suite of analysis tools to power your NGS workflows.

Did you know you can now submit data to BugSeq directly through the @nanoporetech.com EPI2ME platform? Submitting ONT sequence data to BugSeq is now easier than ever! Check out the blog post below for more details on the integration between ONT and BugSeq: epi2me.nanoporetech.com/epi2me-26.04...

EPI2ME 26.04-01 Release

Dear Nanopore Community, We are pleased to announce a new release of EPI2ME Desktop. The highlight…

epi2me.nanoporetech.com

The power of a curated database: BugSeq was most accurate for species identification in an independent evaluation of cloud-based platforms for microbial whole genome sequencing analysis. Read more: doi.org/10.1017/ash....

Miss the recent publication (doi.org/10.1128/jcm....) from @jhu.edu leveraging BugSeq for infection control of C. auris? Stop by our booth at #SHEASpring2026 to learn how BugSeq powers genomic infection control programs. @sheaepi.bsky.social

Detecting healthcare-associated transmission and antifungal resistance in Candida auris via whole genome sequencing | Journal of Clinical Microbiology

Candida auris is a difficult-to-treat yeast that causes invasive infections in vulnerable patient populations. Healthcare exposure is a key risk factor for becoming colonized or infected with C. auris...

doi.org

BugSeq is delighted to partner with the University of British Columbia to improve detection, surveillance and early identification of emerging respiratory pathogens across Canada.

Genome BC@genomebc.bsky.social · 5mo ago

BC researchers are receiving $8M in federal funding to fast-track genomic solutions 🧬 8 teams will advance real-world projects, from pathogen detection to improved care for cancer, Type 1 diabetes and endometriosis. Part of a $20M Genome Canada GAPP investment. 📖: https://tinyurl.com/29kchrhs

Hypervirulent Klebsiella pneumoniae is an emerging concern in clinical microbiology. Read how BugSeq was used to characterize the first cases of hypervirulent K. pneumoniae in Nebraska: doi.org/10.1128/asmc...

Two case reports on the identification and management of hypervirulent Klebsiella pneumoniae isolated in Nebraska, USA | ASM Case Reports

Klebsiella pneumoniae is commonly found in the human gastrointestinal tract and can act as an opportunistic nosocomial pathogen, causing a range of infections such as pneumonia, wounds, and infections...

doi.org

In case you missed it, the recording of the BugSeq + @nanoporetech.com webinar is now available on demand! Discover how Dr. Georgios Kitsios used BugSeq for respiratory metagenomics in the @upmc.com ICU: nanoporetech.com/resource-cen...

Real-time metagenomic sequencing for respiratory infection research

Watch this on-demand webinar on using real-time Oxford Nanopore sequencing for respiratory infection research, metagenomics, and pathogen surveillance.

nanoporetech.com

Oxford Nanopore@nanoporetech.com · 7mo ago

Seeing the full picture of infection, from ICU to surveillance, requires richer data, delivered faster. Join our webinar to learn how new approaches rapidly turn insight into action. Join here: https://bit.ly/4szzhfl

Clinical interpretation and reporting of next-generation sequencing assays is challenging. Check out our recent blog post to learn about how BugSeq leverages machine learning and configurable thresholds to implement evidence-based reporting for your NGS assay. 🧬 → docs.bugseq.com/blog/2026/01...

Don't miss out! Join us on January 14th for an insightful webinar with Dr. Kitsios of @upmc.com. Learn how BugSeq delivers rapid, actionable, and highly accurate results for respiratory #metagenomics in critical care settings. nanoporetech.com/about/events...

Global lessons from metagenomics for future critical care and pathogen surveillance

Join this webinar and learn key technical considerations, optimisations, and training insights for implementing Oxford Nanopore metagenomic workflows in research and surveillance settings.

nanoporetech.com

2025 was an amazing year for sequencing in microbiology! Check out some of our favorite publications from the past year. 🦠 docs.bugseq.com/blog/2025/12...

🚨 BugSeq now supports both EUCAST (new) and CLSI (already supported) breakpoints for the prediction of #AMR. This expansion ensures greater accuracy and global applicability in determining resistance. Get in touch for early access to EUCAST breakpoints on your account.

At #AMPath2025? Here is one more reason why you need to drop by booth 447 to discuss bioinformatics with our team of experts!

🚨 New Publication 🚨 Check out this paper from @mskcancercenter.bsky.social, where BugSeq empowers the center's infection control team to launch an active C. auris surveillance program. WGS informs infection control interventions → doi.org/10.1016/j.jm... #InfectionPrevention #Cauris

Meet BugSeq at #IDWeek2025 - Booth 1329! See how our bioinformatics platform empowers clinical microbiology labs and drives clinically validated assays with customizable reporting thresholds.

Clinical and public health labs need solutions that make sequencing analysis easier. In our upcoming webinar, learn how BugSeq supports pathogen identification, AMR detection, and outbreak surveillance without complex bioinformatics pipelines. Register here: event.on24.com/wcc/r/506648...

Ever wonder how BugSeq is used to identify bacteria, characterize #AMR and track outbreaks in hospitals and the community? Tune in on Sep 29 to hear from Wes Hottel, Bioinformatics Scientist, State Hygienic Laboratory, The University of Iowa: event.on24.com/wcc/r/506648...

C. difficile is the most frequent cause of infectious diarrhea in hospitals and long-term care facilities. Locher et al. used BugSeq to evaluate transmission within @vchhealthcare.bsky.social (doi.org/10.1016/j.mi...). Want to learn more?

NGS has improved pathogen surveillance, but complex bioinformatics pipelines can hold many labs back. Join our upcoming webinar to learn how @bugseq.com makes advanced microbial ID, AMR detection, and outbreak tracking accessible to every lab. Register here: event.on24.com/wcc/r/506648...

🚨 New blog - Bringing Precision Medicine to the ICU: Insights from BugSeq Grant Recipient Dr. Georgios Kitsios (@upmc.com). Read how Dr. Kitsios is leveraging @nanoporetech.com metagenomics to revolutionize diagnosis and management of ventilator-associated pneumonia: docs.bugseq.com/blog/2025/08...

Amaral et al. found a discordance between BIOFIRE BCID2 and #AMR phenotype. Read how BugSeq’s curated database enabled frameshift detection in a CTX-M and accurate phenotype prediction: doi.org/10.1016/j.di...

🚨 Headed to #ADLM2025? Come say hi to the BugSeq team at Booth 1064! We’re showcasing the future of infectious disease assays with rapid, accurate, and interpretable genomic solutions. Let’s talk metagenomics, AMR, and more 🧬👩‍🔬 #ADLM2025 #microbiology #genomics #AMR @myadlm.bsky.social